Qsam Biosciences Stock Total Debt
| QSAMDelisted Stock | USD 4.49 0.05 1.13% |
Qsam Biosciences fundamentals help investors to digest information that contributes to Qsam Biosciences' financial success or failures. It also enables traders to predict the movement of Qsam OTC Stock. The fundamental analysis module provides a way to measure Qsam Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Qsam Biosciences otc stock.
Qsam |
Qsam Biosciences OTC Stock Total Debt Analysis
Qsam Biosciences' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Qsam Biosciences Total Debt | 7.5 K |
Most of Qsam Biosciences' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Qsam Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Qsam Biosciences has a Total Debt of 7.5 K. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The total debt for all United States stocks is 100.0% higher than that of the company.
Qsam Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Qsam Biosciences' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Qsam Biosciences could also be used in its relative valuation, which is a method of valuing Qsam Biosciences by comparing valuation metrics of similar companies.Qsam Biosciences is currently under evaluation in total debt category among its peers.
Qsam Fundamentals
| Return On Equity | -33.77 | |||
| Return On Asset | -2.38 | |||
| Current Valuation | 36.03 M | |||
| Shares Outstanding | 4.45 M | |||
| Shares Owned By Insiders | 52.36 % | |||
| Price To Book | 201.64 X | |||
| Price To Sales | 1.71 X | |||
| Gross Profit | 916.67 K | |||
| EBITDA | (3.94 M) | |||
| Net Income | (4.39 M) | |||
| Cash And Equivalents | 429.35 K | |||
| Cash Per Share | 0.25 X | |||
| Total Debt | 7.5 K | |||
| Debt To Equity | 2.08 % | |||
| Current Ratio | 0.23 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (2.85 M) | |||
| Earnings Per Share | (1.69) X | |||
| Beta | 1.81 | |||
| Market Capitalization | 73.79 B | |||
| Total Asset | 1.71 M | |||
| Retained Earnings | (40.16 M) | |||
| Working Capital | 672.35 K | |||
| Net Asset | 1.71 M |
About Qsam Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Qsam Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Qsam Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Qsam Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Qsam Biosciences information on this page should be used as a complementary analysis to other Qsam Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Qsam OTC Stock
If you are still planning to invest in Qsam Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Qsam Biosciences' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |